Dr Adrien Rousseau
MRC PPU, School of Life Sciences
Accumulation of unfolded, misfolded, or damaged proteins is deleterious to cells. To avoid such potentially harmful conditions, cells have evolved efficient protein quality control systems which act in a concerted manner to maintain proteostasis. Among them, the ubiquitin-proteasome system (UPS) is one of the major systems in charge of the degradation of short-lived, damaged and misfolded proteins, which makes it a pivotal player in the regulation of various cellular functions. Increasing evidence reveals that alterations and mutations in components of the UPS, are an underlying cause of various age-related diseases, most prominently cancers and neurodegenerative disorders.
The goal of our lab is to unravel the crosstalk between protein phosphorylation and proteasomal degradation, especially how phosphorylation regulates protein degradation to meet the cell’s requirements. We are also aiming at developing new tools to decipher how the proteasome is regulated in cells as well as to identify new drugs and regulators modulating its function. Both yeast and mammalian systems are used to tackle these questions.
We have recently identified an evolutionarily conserved pathway controlling proteasome homeostasis, with TORC1 inhibition inducing the levels of 19S regulatory particle assembly chaperones (RACs) and the assembly of the 26S proteasome under stressful conditions. Downstream of TORC1 inhibition, the kinase Mpk1 orchestrates the inductions of RACs and proteasome assembly. This work illustrates that proteasomal degradation is regulated under stressful conditions, an essential adaptive mechanism for cells to survive. Thus, understanding how cells adapt protein degradation to the needs might help to identify new therapeutic targets to rescue proteostasis defects in diseases.
- Adrien Rousseau and Anne Bertolotti (2016) An evolutionarily conserved pathway controls proteasome homeostasis. Nature 536 184–189
- Ariane Hanssum, Zhen Zhong, Adrien Rousseau, Agnieszka Krzyzosiak, Anna Sigurdardottir and Anne Bertolotti (2014) An inducible chaperone adapts proteasome assembly to stress Mol. Cell 55 566–577
- Adrien Rousseau, Catherine Tomasetto and Fabien Alpy (2014) The phosphoinositide-binding protein TRAF4 modulates tight junction stability and migration of cancer cells Tissue Barriers 2 e975597
- Adrien Rousseau, Léa P Wilhelm, Catherine Tomasetto and Fabien Alpy (2014) TRAF4, a multifaceted protein involved in carcinoma progression Biol. Aujourdhui 208 299–310
- Adrien Rousseau, Alastair Mc Ewen, Pierre Poussin, Didier Rognan, Yves Nominé, Marie-Christine Rio, Catherine Tomasetto and Fabien Alpy (2013) TRAF4 is a novel phosphoinositides binding protein modulating tight junctions and favoring cell migration PLoS Biol 11(12) e100172
Researchers from Adrien Rousseau’s lab in the MRC Protein Phosphorylation and Ubiquitylation Unit at the University of Dundee, Scotland, have identified mechanisms contributing to the stress-induced increase in proteasome abundance using yeast.
Adrien Rousseau has opened a new laboratory in the MRC PPU to investigate signalling pathways controlling proteasome homeostasis.
Signalling pathways controlling proteasome homeostasis